SEC Form 4 · accession 0001209191-18-011629
HCA Healthcare, Inc. · HCA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Alan R Yuspeh
Officer — SVP & Chief Ethics Officer
Period of report
Feb 16, 2018
Accepted (ET)
Feb 20, 2018 · 8:08 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000860730
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Feb 16, 2018 | M | 12,375 | $37.18 | A | 35,031 | D | |
| Common Stock | Feb 16, 2018 | F | 6,497 | $101.00 | D | 28,534 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Appreciation RightF1 | $37.18 | Feb 16, 2018 | M | 6,875 | D | — | Feb 6, 2023 | Common Stock | 6,875 | 0 | D |
| Stock Appreciation RightF2 | $37.18 | Feb 16, 2018 | M | 5,500 | D | — | Feb 6, 2023 | Common Stock | 5,500 | 0 | D |
Explanation of responses
- F1The stock appreciation rights vested in four equal annual installments beginning on February 6, 2014.
- F2The stock appreciation rights vested at the end of fiscal years 2013, 2014, 2015 and 2016 based upon the achievement of certain annual EBITDA performance targets.